By contrast, MSCs did not present the innate anti-tumor actions but the overexpression of Lrp5 converted them into anti-tumor agents by reducing the MTT-based viability and downregulating MMP9, Runx2, and Snail, as well as N-cadherin in EO771 cells (Figure 8E,F). The gene discussed is LRP5; the disease is neoplasm.